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The purpose of this report is to define the underlying 
cause of an electroretinogram (ERG) abnormality noted in a 
transgenic mouse line (tg21) designed to overexpress eryth-
ropoietin (Epo) in the retina and the brain. The original goal 
of the study was to evaluate the potential of Epo for neuro-
protection since Epo is beneficial in several animal models 
[1-3]. ERG analysis of multiple tg21 animals noted that the 
ERG a-wave, reflecting activity of retina photoreceptors [4], 
was retained while the b-wave, representing the response of 
depolarizing bipolar cells (DBCs) [5], was absent. This no-b-
wave (nob) phenotype was similar to that reported for mouse 
models of DBC dysfunction due to mutations in Nyctalopin 
(Nyx) [6], G-protein coupled receptor 179 (Gpr179) [7], 
Glutamate receptor metabotropic 6 (Grm6) [8], or Transient 
receptor potential cation channel subfamily M member 1 
(Trpm1) [9-12].
To understand the basis of the nob ERG phenotype of tg21 
mice, we conducted a series of morphological and molecular 
studies to evaluate potential explanations. We also performed 
a mapping cross to identify the locus of the gene involved. 
These studies demonstrated that the nob ERG phenotype was 
not associated with a loss of retinal neurons including DBCs, 
or abnormal retinal vasculature. In fact, the ERG nob pheno-
type was inherited independently of the tg21 transgene. We 
measured gene expression levels for Nyx, Gpr179, Grm6, and 
Trpm1 and found that Gpr179 was significantly decreased in 
affected animals. Further analysis indicated that the nob ERG 
phenotype reflected a large insertion in the Gpr179 locus, the 
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Purpose: To identify the mutation responsible for an abnormal electroretinogram (ERG) in a transgenic mouse line 
(tg21) overexpressing erythropoietin (Epo). The tg21 line was generated on a mixed (C3H; C57BL/6) background and 
lacked the b-wave component of the ERG. This no-b-wave (nob) ERG is seen in other mouse models with depolarizing 
bipolar cell (DBC) dysfunction and in patients with the complete form of congenital stationary night blindness (cCSNB). 
We determined the basis for the nob ERG phenotype and screened C3H mice for the mutation to evaluate whether this 
finding is important for the vision research community.
Methods: ERGs were used to examine retinal function. The retinal structure of the transgenic mice was investigated us-
ing histology and immunohistochemistry. Inverse PCR was performed to identify the insertion site of the Epo transgene 
in the mouse genome. Affected mice were backcrossed to follow the inheritance pattern of the nob ERG phenotype. 
Quantitative real-time PCR (qRT PCR), Sanger sequencing, and immunohistochemistry were used to identify the muta-
tion causing the defect. Additional C3H sublines were screened for the detected mutation.
Results: Retinal histology and blood vessel structure were not disturbed, and no loss of DBCs was observed in the 
tg21 nob mice. The mutation causing the nob ERG phenotype is inherited independently of the tg21 transgene. The 
qRT PCR experiments revealed that the nob ERG phenotype reflected a mutation in Gpr179, a gene involved in DBC 
signal transduction. PCR analysis confirmed the presence of the Gpr179nob5 insertional mutation in intron 1 of Gpr179. 
Screening for mutations in other C3H-derived lines revealed that C3H.Pde6b+ mice carry the Gpr179nob5 allele whereas 
C3H/HeH mice do not.
Conclusions: We identified the presence of the Gpr179nob5 mutation causing DBC dysfunction in a C3H-derived trans-
genic mouse line. The nob phenotype is not related to the presence of the transgene. The Gpr179nob5 allele can be added 
to the list of background alleles that impact retinal function in commonly used mouse lines. By providing primers to 
distinguish between Gpr179 mutant and wild-type alleles, this study allows investigators to monitor for the presence of 
the Gpr179nob5 mutation in other mouse lines derived from C3H.
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same mutation recently reported in Gpr179nob5 mice [7], and 
that this mutation is present in additional C3H-derived mouse 
lines. We provide evidence that mice investigated by Hoelter 
and colleagues characterized by a nob ERG phenotype carry 
the Gpr179nob5 mutation [13]. These observations indicate 
that the Gpr179nob5 mutation likely appeared many years ago, 
and that it may be present in additional lines beyond those 
examined here.
METHODS
Mice: The tg21 mice were originally generated to study 
the effect of constitutively overexpressed Epo in vascular 
diseases [14] and were provided by Prof. Max Gassmann, 
University of Zürich. They were bred to create a line homo-
zygous for the transgene and were maintained in a 12 h:12 h 
light-dark cycle with food and water ad libitum. To map the 
trait underlying the nob ERG phenotype, affected tg21 mice 
were mated to DBA/2N mice (Charles River WIGA, Sulzfeld, 
Germany) to generate F1 progeny. F1 mice were intercrossed 
to generate the F2 progeny used for mapping based on ERG 
analysis. C57BL/6 mice were obtained from Charles River. 
Experiments were conducted according to the Association for 
Research in Vision and Ophthalmology (ARVO) Statement 
for the Use of Animals in Ophthalmic and Vision Research 
following government approval.
We also examined genomic DNA from C3H/HeH and 
C3H.Pde6b+ mice generously provided by Dr. Martin Fray 
(MRC Harwell, Oxfordshire, UK) and from C57BL/6 and 
Gpr179nob5 mice.
Molecular cloning of the erythropoietin insertion site in 
tg21: Genomic DNA was isolated using the Gen Elute 
Mammalian Genomic DNA Miniprep Kit (Sigma Aldrich, 
St. Louis, MO). Inverse PCR was used to clone sequences 
flanking the Epo transgene. Briefly, primers were designed 
to the known sequence adjacent to an EcoRI restriction site 
located in the known platelet-derived growth factor (PDGF) 
promoter. Following enzymatic digestion using EcoRI, the 
enzyme was inactivated by heating at 65 °C for 15 min, the 
DNA was diluted, and T4 DNA ligase added to circularize the 
EcoRI fragments. This DNA was used as input for PCR using 
AccuPrime Taq Polymerase (Invitrogen Life Technologies, 
Carlsbad, CA) and the primer pair tg21 inv1 and tg21 inv2 
(Table 1) as recommended by the manufacturer. A 600 bp 
junction fragment was amplified and sequenced to identify 
the genomic insertion site of the tg21 Epo transgene.
For genotyping purposes, genomic DNA was isolated 
as described, and F2 animals were genotyped for the Epo 
insertion and for markers specific to the wild-type flanking 
sites of the Epo insertion site. Primers used are listed in Table 
1. The Epo insert was identified with PCR using the primers 
5′-hPDGF of the human promoter and the 3′-hPDGF primer 
[15]. To differentiate between tg21/tg21 homozygous and 
tg21/+ heterozygous animals, a PCR using primers on chro-
mosome 8 (Primer Chr8–01, Chr8–03) that flank the trans-
gene was used. PCR amplifications were performed using the 
iQ SYBR Green Supermix (BioRad, Cressier, Switzerland) 
on a MyiQ single color Real-time PCR detection system 
(BioRad). Cycling conditions were 45 cycles comprising a 
30 s step of denaturation at 95 °C, a 30 s annealing step at 
60 °C (for Chr8–01/Chr8–03 primers) or 64 °C (for hPDGF 
primers), and a 30 s extension period at 72 °C.
Electroretinography: Animals were dark-adapted overnight, 
and all procedures were performed under dim red light. 
Mice were anesthetized with an intraperitoneal injection of 
ketamine (80 mg/kg; Ketalar, Pfizer, Zürich, Switzerland) 
and medetomidine (1 mg/kg; Domitor; Orion Pharma, 
Espoo, Finland). Pupils were dilated with eye drops (2.5% 
phenylephrine + 0.5% tropicamide; MIX-Augentropfen, ISPI, 
Bern, Switzerland), and the anesthetized mice were placed 
on a temperature-controlled heating table (Roland Consult, 
Brandenburg, Germany). ERGs were recorded simultaneously 
from both eyes with gold wire electrodes, which touched the 
central cornea of each eye and were wetted with 1% meth-
ylcellulose (OmniVision, Santa Clara, CA). A gold wire 
electrode (0.2 mm diameter) placed in the mouth was used 
as a reference electrode, and another electrode positioned on 
the tail served as the ground electrode. Strobe flashes of light 
were presented in a Q400 Ganzfeld bowl, and responses were 
amplified, averaged, and stored using a RetiScan-RetiPort 
electrophysiology unit (Roland Consult, Brandenburg, 
Germany). ERGs were obtained to 0.47 log cd∙s/m2 strobe 
flash stimuli presented in the dark or superimposed upon a 
steady adapting field (25 cd/m2), following a 10 min light 
adaption period.
Table 1. Primers
Primer name Primer sequence (5′ – 3′)
tg21inv1 CCAGGGCAGGATCTGAATTC
tg21inv2 CCCTCCATCTAGCCTCAACC
Chr8–01 CCCACCATGTGACAAAACTA
Chr8–03 CAGCTCTGGTAAAGGAGGAA
hPDGF fwd CCATCTCCAGGTTGAGGC
hPDGF rev GTCTCTGAGAGCCGAGC
Gpr179 fwd TGTGCCTGGGTATCTGTTGA
Gpr179 rev GCTTACACACTTACACACAGATAGAT
Gpr179 insert GCATGTGCCAAGGGTATCTT
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Histology and immunohistochemistry: Mouse eyecups 
were freshly prepared by removing the cornea and the lens. 
Following fixation in 4% paraformaldehyde (PFA), the tissue 
was snap frozen in optimum cutting temperature (OCT) 
compound or embedded in paraffin, and either 7 µm (OCT) 
or 5 µm (paraffin) thick sections were cut.
Sagittal paraffin sections at the level of the optic nerve 
head were stained with hematoxylin and eosin and used 
for retinal thickness measurements. The thickness of each 
cellular and plexiform layer was calculated using ImagePro 
software (Media Cybernetics, Rockville, MD) at six different 
locations (400, 1,000, and 1,600 µm inferior and superior to 
the edge of the ONH).
Paraffin sections were rehydrated and, following antigen 
retrieval, permeabilized and incubated with blocking solu-
tion (10% normal goat serum and 1% bovine serum albumin 
dissolved in TBS (Tris-buffered Saline; 50 mM Tris-HCl, 
150 mM NaCl, pH 7.5) supplemented with 0.025% Tween-
20) for 1 h. Sections were then incubated with the primary 
antibody (anti-protein kinase C alpha, 1:500; Sigma Aldrich, 
Buchs, Switzerland) at 4 °C overnight. As a secondary anti-
body, a goat anti-mouse Alexa Fluor 488 antibody (1:500; 
Invitrogen, Carlsbad, CA) was used.
Cryosections were blocked (5% horse serum/0.5% 
Tween-20 in TBS) for 1 h and incubated with primary anti-
body (sheep anti-Gpr179 [7] 1:1,000 in 5% horse serum/0.5% 
Tween-20 in TBS) at 4 °C overnight. A secondary antibody, 
donkey anti-sheep Alexa Fluor 594 (Invitrogen), was applied 
in a 1:500 dilution for 45 min. After staining, the sections 
were mounted using 4’,6-diamidino-2-phenylindole dihydro-
chloride Vectashield (Vector Laboratories, Orton Southgate, 
UK).
The retinal vasculature was visualized using a published 
procedure [16]. Briefly, eyes were enucleated and fixed in 
2% PFA for 5 min. Following removal of lens and cornea, the 
sensory retina was dissected out, flattened and postfixed in 
4% PFA for another 10 min. Flat mounts were then incubated 
for 1 h in blocking solution consisting of 1% fetal bovine 
serum diluted in 0.1% Triton X-100 in phosphate buffered 
saline. Retinas were incubated overnight in Griffonia simplic-
ifolia isolectin IB4-Alexa488 (Life Technologies, Carlsbad 
CA) diluted 1:1000 in blocking solution. Following washing 
steps, flat mounts were mounted using fluorescent mounting 
medium (DAKO, Baar, Switzerland) and digital images were 
recorded using a confocal microscope (Zeiss LSM 710; Carl 
Zeiss, Jena, Germany).
Quantitative reverse transcription polymerase chain reaction 
for bipolar cell genes: TaqMan Gene expression assays were 
used to compare expression levels of DBC genes. Following 
RNA isolation of retinal tissues, reverse transcription was 
performed using the SuperScript II First-Strand Synthesis 
System (Invitrogen). PCR amplifications on cDNA were 
conducted using the TaqMan gene expression assays on 
a Real-Time PCR System (7900HT; Applied Biosystems, 
Life Technologies, Foster City, CA) according to the manu-
facturer’s instructions. Values were normalized to control 
measures, and actin served as the internal standard.
Detection of the Gpr179nob5 mutation: To confirm the presence 
of a mutation in intron 1 of Gpr179, mouse-specific primers 
(Gpr179 forward, Gpr179 reverse; Table 1) were designed to 
amplify an intron fragment that encompassed the transposon 
insertion site in Gpr179 mice. Sequencing of a PCR fragment 
enabled the design of a primer (Gpr179 insert; Table 1) on the 
insertion site. To identify the position of the insertion site 
in the mouse genome, the BLAT program (UCSC Genome 
Browser) was used.
PCR amplifications were performed as described using 
an annealing step at 60 °C and a mix of all three Gpr179 
primers (Table 1) and genomic DNA as the template. PCR 
products were analyzed on 2.5% agarose gels stained with 
ethidium bromide and visualized using the Versa Doc 
Imaging System (BioRad).
RESULTS
Identification of a no-b-wave electroretinogram pheno-
type: During the course of the baseline ERG studies of tg21 
animals, we observed that animals from this line lacked the 
b-wave. In Figure 1, representative ERGs obtained from a 
tg21 mouse and a C57BL/6 mouse are compared in response 
to 0.47 log cd s/m2 stimuli presented under either dark-
adapted (left) or light-adapted (right) conditions. Under both 
adaptation conditions, the ERGs obtained from the tg21 mice 
were markedly abnormal. In the dark-adapted state, the ERGs 
of the tg21 mice lacked the b-wave that normally follows the 
a-wave. Under light-adapted conditions (right), the major 
positive component of the cone ERG was reduced in the tg21 
mice.
Retinal histology, bipolar cell morphology, and retinal 
vasculature are normal in tg21 no-b-wave mice: To dissect 
the basis for the nob ERGs of the tg21 mice, we examined 
the overall retinal structure. In Figure 2A, the retinal cross 
sections obtained from a non-transgenic mouse with a normal 
b-wave (left) are compared with those of a tg21 nob mouse 
(right). All cellular and plexiform layers are present in the 
tg21 nob retina, which is generally comparable to that of the 
wild-type (WT) retina. This impression was confirmed when 
each cellular and plexiform layer was measured. As shown 
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in Figure 2B, there was no significant difference between the 
retinal morphology of the WT and tg21 nob mice, including 
the inner nuclear layer (INL), where DBC cell bodies are 
located.
To examine whether the ERG phenotype of tg21 nob 
mice might reflect a loss of DBCs [17], we assessed DBC 
morphology using the DBC marker anti-protein kinase C 
alpha. As shown in Figure 3, DBCs are present in the tg21 
nob retina, and their appearance is comparable to that of WT 
DBCs.
ERG b-wave amplitudes are sensitive to changes in 
ocular blood f low [18] and can be strongly reduced or 
increased upon changes in inner retinal blood flow [19]. 
High increases in retinal and blood plasma Epo levels have 
been associated with changes in the retinal vasculature of 
mice [19]. To evaluate the vasculature of tg21 nob mice, we 
used immunohistochemistry on retinal flat mounts to assess 
retinal blood vessels. No significant difference was detectable 
in vessel structure (primary, intermediate, and deep plexus) 
between the tg21 nob and WT animals with a normal ERG 
b-wave (Figure 4).
The electroretinogram phenotype of tg21 no-b-wave mice is 
not due to the erythropoietin insertion: The results presented 
in Figure 2, Figure 3, and Figure 4 indicate that the nob ERG 
phenotype of tg21 mice is not caused by mechanisms that 
have been reported in other mouse lines, including abnormal 
retinal architecture [20], loss of DBCs [17], or alterations in 
blood flow to the inner retina [19]. To evaluate the possibility 
that the phenotype reflects a mutation due to the transgene 
insertion site [21], we used a PCR approach to clone a junc-
tion fragment with the 5′ end of the tg21 transgene. Sequence 
analyses identified a 115 bp fragment from mouse chromo-
some 8 (chr8:51,016,110–51,016,224, mm10). Examination 
of the genome in this region indicated that the insertion site 
was located in a gene desert devoid of any annotated genes. 
As a consequence, the nob ERG phenotype does not reflect 
an insertion of the transgene into a gene locus known to be 
required for normal DBC function.
To determine whether the nob ERG phenotype coseg-
regated with tg21, we used a standard mapping approach in 
which tg21 homozygous mice were crossed to DBA/2N mice 
and the resulting F1 animals were intercrossed (Figure 5A). 
All F1 mice displayed a normal ERG, indicating that the nob 
ERG trait is recessive. A total of 98 F2 mice were examined 
with ERG and genotyped for the presence of a chr8:tg21 junc-
tion fragment or the WT allele at the tg21 insertion location 
(Figure 5B). As summarized in Figure 5A, 19 F2 animals 
(19.3%) lacked the ERG b-wave, and four of them did not 
inherit the tg21 transgene. Figure 5B shows the genotyping 
data for eight mice, including one (mouse #3) that was non-
transgenic and had a nob ERG. These results indicate that the 
nob ERG phenotype and tg21 are inherited independently.
The tg21 background carries the Gpr179nob5 mutation: To 
investigate whether the nob ERG phenotype is due to a muta-
tion in a gene known to be critical to DBC function, we exam-
ined the expression levels of Nyx, Gpr179, Grm6, and Trpm1 
using qRT PCR (TaqMan assays). Figure 6 shows the expres-
sion level for these genes in C57BL/6, C3H, Gpr179nob5, and 
tg21 nob mice. We detected only marginal Gpr179 expression 
in tg21 nob mice, as well as in the Gpr179nob5 mutant mice run 
as a positive control. In the tg21 nob mice, Gpr179 expres-
sion was decreased about 370-fold compared to the C57BL/6 
controls (Figure 6), a reduction comparable to that reported 
in the Gpr179nob5 mutant mouse [7]. To confirm that GPR179 
is reduced, we compared the distribution of GPR179 in the 
retina of WT and tg21 nob mice. As shown in Figure 7, a 
robust punctate GPR179 label was observed in the outer plexi-
form layer of the WT animals with a normal ERG b-wave. In 
comparison, we did not detect GPR179 in tg21 nob mice. This 
finding confirmed that the mutation underlying the nob ERG 
phenotype results in a massive loss of GPR179 expression.
The Gpr179nob5 mutation arose on a C3H-derived line 
[7]. To determine whether the mutation underlying the 
tg21 nob phenotype might be the same mutation, we used 
Figure 1. Electroretinograms (ERGs) were recorded from 6-week 
old tg21 animals (blue tracings) and C57BL/6 WT mice (black trac-
ings) in response to 0.47 log cd∙s/m2 strobe flashes presented under 
dark-adapted (left) or light-adapted (right) recording conditions. In 
comparison to the wild type (WT) response, the b-wave component 
is markedly reduced in tg21 mice. 
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primers developed to genotype the Gpr179nob5 allele (Figure 
8). These primers correctly identified each nob ERG mouse 
we examined (Figure 9), indicating that the Gpr179nob5 allele 
underlies the nob ERG phenotype we encountered in the tg21 
transgenic line. To confirm that this mutation is identical, we 
compared the junction fragment sequence of the insertional 
mutation and found these were identical (data not shown).
Gpr179nob5 allele is present in C3H “sighted” mice: These 
data suggest that the Gpr179nob5 allele arose on a common 
background, and may be present in other lines derived from 
C3H. Hoelter and colleagues [13] reported a line of “sighted” 
C3H.Pde6b+ mice in which the Pde6rd1 locus was replaced 
by the WT allele, and did not develop the photoreceptor 
degeneration characteristic of C3H/HeH mice. These mice 
retained a normal ERG a-wave, but lacked the b-wave [13]. 
When we examined DNA samples from C3H/HeH and C3H.
Figure 2. Normal retinal structure is 
visible in tg21 nob mice. A: Retinal 
cross-sections obtained from 
6-week old non-transgenic (left) 
and tg21 nob (right) littermates. The 
appearance of the WT and tg21 nob 
retinas is comparable. B: Thickness 
of individual plexiform or cellular 
layers was assessed in WT and tg21 
nob retinas. There was no signifi-
cant difference observable in any 
retinal layer. Bars indicate mean 
(± S.D. of 4 mice). Abbreviations: 
ONL represents the outer nuclear 
layer; OPL represents the outer 
plexiform layer; INL represents the 
inner nuclear layer; IPL represents 
the inner plexiform layer; GCL 
represents the ganglion cell layer.
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Pde6b+ mice, we observed that C3H.Pde6b+ mice carry the 
Gpr179nob5 allele (Figure 10).
DISCUSSION
In this study, we evaluated the basis for the nob ERG pheno-
type identified in a line of transgenic mice overexpressing 
Epo in the brain and the retina. The nob ERG phenotype does 
not reflect a loss of DBCs or some other abnormality in the 
retinal structure, as all measures in the tg21 nob retinas were 
comparable to WT. When tg21 mice were crossed to a WT 
strain (DBA/2N), we observed that the nob ERG phenotype 
was inherited independently of the tg21 transgene. This 
observation proves that the nob ERG phenotype is not caused 
by the tg21 transgene product or insertion site. When we 
examined the expression of several genes required for normal 
DBC function, we found that the expression of Gpr179 was 
markedly reduced. Further analysis indicated that the nob 
mice studied here carry the Gpr179nob5 allele recently identi-
fied in a mouse line also derived from C3H [7]. To evaluate 
whether this allele is present elsewhere, we examined another 
Figure 3. Retinal cross sections 
were stained for normal depolar-
izing bipolar cell function using 
an antibody against protein kinase 
C alpha (PKCα; green) and with a 
cell body label (blue). Depolarizing 
bipolar cells (DBCs) are present 
in the tg21 no b-wave (nob) retina 
(right), with a distribution that is 
comparable to that of non-trans-
genic (left) littermates.
Figure 4. Comparison of retinal 
vasculature performed using retinal 
whole mounts of non-transgenic 
(left) and tg21 (right) littermates. 
Whole mounts were prepared with 
the inner retina facing upward, and 
stained for vascular endothelial 
cells using isolectin IB4.
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nob mouse, the “sighted” C3H.Pde6b+ mouse. The Gpr179nob5 
allele was also present in that line in which the Pde6brd1 allele 
was removed. However, the mutation was not found in C3H/
HeH mice that carry the Pde6rd1 allele. These results indi-
cate that the Gpr179nob5 allele was present in the background 
strain on which the tg21 transgenic line was established or 
was carried by the subsequent strains used to maintain this 
line. In that regards, it is possible that tg21 bred in other 
research laboratories do not carry the Gpr179nob5 allele, since 
the tg21 transgene and the Gpr179nob5 allele might be inherited 
independently resulting in the potential for the WT Gpr179 
allele to be crossed into the transgenic line.
Identifying the Gpr179nob5 allele in a C3H-derived line 
raises the possibility that it may be present in additional 
mouse lines. There is certainly precedent for an allele that 
negatively impacts retinal function to be widespread. For 
example, the Pdeb6rd1 allele results in a rapid degeneration of 
rod and cone photoreceptors and has been identified in many 
mouse strains [22,23]. The Crb1rd8 allele causes ocular lesions 
[24] and has been identified in multiple inbred mouse strains 
[25]. The Gnat2cpfl3 results in one photoreceptor dysfunction 
Figure 5. The nob ERG phenotype 
does not segregate with the tg21 
transgene. A: Pedigree of a two-
generation cross between tg21 
no-b-wave and DBA/2N mice. All 
F1 offspring had normal electro-
retinograms (ERGs). A: Of 98 F2 
progeny, 19 mice had a no-b-wave 
(nob) ERG phenotype; of these, 
four were non-transgenic (DBA). B: 
Genotyping demonstrated that tg21 
and the nob ERG phenotype do not 
cosegregate. Note that mouse #3 is 
non-transgenic and has a nob ERG.
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and was recently identified in several inbred lines [26]. We 
have not conducted a thorough survey of inbred mouse lines, 
but the Gpr179nob5 allele could be present in additional mouse 
lines, particularly those related to C3H, as each line known to 
carry this allele was derived from that background. Although 
the Gpr179nob5 allele was not present in any commercially 
available C3H lines, our observation that the identical 
mutation has been identified on both sides of the Atlantic 
on a sighted C3H background suggests this allele may be 
widespread, although its presence could be masked by the 
presence of the rd1 allele. In conclusion, should a nob ERG 
phenotype be encountered during the course of evaluating 
Figure 6. Expression levels of 
several genes required for normal 
depolarizing bipolar cell (DBC) 
function in several mouse lines. 
Note that expression of Gpr179 
was decreased 370-fold in the 
tg21 no b-wave (nob) mice and 
in Gpr179nob5 mutant mice. Other 
depolarizing bipolar cell (DBC) 
genes were expressed at normal or 
slightly higher than normal levels 
in the tg21 nob and Gpr179nob5 
mice. Values were normalized to 
control measures and actin served 
as the internal standard. Values are 
expressed as mean±SD (n=3).
Figure 7. Retinal cross-sections 
obtained from tg21 mice no b-wave 
mice and control littermates were 
stained for GPR179. Positive 
staining is seen as punctate distri-
bution in the outer plexiform layer 
of control mice, and is absent from 
retinas of tg21 no b-wave (nob) 
mice. Abbreviations: OPL repre-
sents the outer plexiform layer; 
ONL represents the outer nuclear 
layer; INL represents the inner 
nuclear layer.
Molecular Vision 2013; 19:2615-2625 <http://www.molvis.org/molvis/v19/2615> © 2013 Molecular Vision 
2623
Figure 8. Representation of a 6.5 
kb insertion in intron 1 of Gpr179 
identified with polymerase chain 
reaction using an intron-specific 
primer and subsequent Sanger 
sequencing. The schematic indi-
cates the presence of the mutation 
in intron 1 of Gpr179. The sequence 
obtained with PCR with an intron-specific primer (Gpr179 rev) was used to design the mutation-specific primer. All three Gpr179 primers 
(Table 1) were used for genotyping.
Figure 9. Agarose gel visualization 
of genotyped genomic deoxyri-
bonucleic acid samples of mice 
screened for the Gpr179nob5 allele 
and examined with electroretino-
gram. The yellow box highlights 
the observation that the no-b-wave 
(nob) electroretinogram (ERG) 
phenotype was observed only in 
mice that were homozygous for the 
Gpr179nob5 allele.
Figure 10. Polymerase chain reac-
tion was performed on genomic 
deoxyribonucleic acid obtained 
from two C3H lines (C3H/HeH and 
C3H.Pde6b+) using the Gpr179nob5 
pr imers. Cont rol mice were 
C57BL6 and the well-described 
nob5 mouse mutant [7]. C3H.
Pde6b+ was homozygous mutated 
for Gpr179.
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a mouse line, it would be efficient to evaluate whether the 
Gpr179nob5 allele may be responsible. If this is the case, the 
mutation has to be outcrossed before the animals are used for 
visual function experiments.
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